These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 15177065)
1. Apomorphine delays simple reaction time in Parkinsonian patients. Müller T; Benz S; Przuntek H Parkinsonism Relat Disord; 2002 Jun; 8(5):357-60. PubMed ID: 15177065 [TBL] [Abstract][Full Text] [Related]
2. Differential response in choice reaction time following apomorphine based on prior dopaminergic treatment. Müller T; Benz S; Börnke C; Przuntek H Acta Neurol Scand; 2004 May; 109(5):348-54. PubMed ID: 15080862 [TBL] [Abstract][Full Text] [Related]
3. Delay of simple reaction time after levodopa intake. Müller T; Benz S; Börnke C Clin Neurophysiol; 2001 Nov; 112(11):2133-7. PubMed ID: 11682352 [TBL] [Abstract][Full Text] [Related]
4. Movement characteristics in Parkinson's disease: determination of dopaminergic responsiveness and threshold. van Hilten JJ; Wagemans EA; Ghafoerkhan SF; van Laar T Clin Neuropharmacol; 1997 Oct; 20(5):402-8. PubMed ID: 9331516 [TBL] [Abstract][Full Text] [Related]
5. [Subcutaneous apomorphine injection: rescue management of motor fluctuations associated with levodopa-therapy]. Yamada K; Miyauchi N; Kanda T Nihon Yakurigaku Zasshi; 2013 Jan; 141(1):44-51. PubMed ID: 23302948 [No Abstract] [Full Text] [Related]
6. Preclamol and parkinsonian fluctuations. Pirtosek Z; Merello M; Carlsson A; Stern G Clin Neuropharmacol; 1993 Dec; 16(6):550-4. PubMed ID: 9377590 [TBL] [Abstract][Full Text] [Related]
7. Sleep attacks with apomorphine. Homann CN; Suppan K; Wenzel K; Ivanic G; Kriechbaum N; Ott E Wien Klin Wochenschr; 2002 Jun; 114(10-11):430-1. PubMed ID: 12708100 [No Abstract] [Full Text] [Related]
16. Open-label study assessment of safety and adverse effects of subcutaneous apomorphine injections in treating "off" episodes in advanced Parkinson disease. LeWitt PA; Ondo WG; Van Lunen B; Bottini PB Clin Neuropharmacol; 2009; 32(2):89-93. PubMed ID: 18978491 [TBL] [Abstract][Full Text] [Related]
17. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome. Reuter I; Ellis CM; Ray Chaudhuri K Acta Neurol Scand; 1999 Sep; 100(3):163-7. PubMed ID: 10478579 [TBL] [Abstract][Full Text] [Related]
18. [Apomorphine for treatment of "off-periods" in Parkinson's disease]. Zoldan J; Merims D; Kuritzky A; Ziv I; Melamed E Harefuah; 1999 Nov; 137(10):444-6, 512, 511. PubMed ID: 10959339 [TBL] [Abstract][Full Text] [Related]
19. Future delivery systems for apomorphine in patients with Parkinson's disease. van Laar T; Van der Geest R; Danhof M Adv Neurol; 1999; 80():535-44. PubMed ID: 10410768 [No Abstract] [Full Text] [Related]